Non Invasive Diagnostic of Endometrial Receptivity

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Carlos Simon, Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier:
NCT01588223
First received: April 26, 2012
Last updated: March 26, 2014
Last verified: March 2014
  Purpose

The purpose of this study is to determine a lipidomic profile on the endometrial fluid, that can predict endometrial receptivity.


Condition Intervention
Endometrial Receptivity Failure
Other: Lipid identification

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: A Non Invasive Diagnostic of Endometrial Receptivity Based on Lipidomic Profile on Endometrial Fluid.

Further study details as provided by Igenomix:

Primary Outcome Measures:
  • Levels of lipids in the endometrial fluid as a diagnostic factor. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Enrollment: 40
Study Start Date: January 2011
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lipids Other: Lipid identification
The lipids are identified using Mass Spectrometry

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Oocyte donors undergoing controlled ovarian stimulation
  • Regular menstrual cycles
  • no abnormal karyotype
  • generally healthy
  • BMI 19-29 Kg/m2 (both inclusive)
  • 18 to 35 years old.

Exclusion criteria:

-patients diagnosed with endometriosis and/or endometritis.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01588223

Locations
Spain
IVI Valencia
Valencia, Spain, 46015
Sponsors and Collaborators
Igenomix
  More Information

No publications provided

Responsible Party: Carlos Simon, Prof. Carlos Simon, MD PhD, Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier: NCT01588223     History of Changes
Other Study ID Numbers: 1002-C-069-OB
Study First Received: April 26, 2012
Last Updated: March 26, 2014
Health Authority: Spain: Ministry of Health

ClinicalTrials.gov processed this record on August 28, 2014